Added to YB: 2025-01-03
Pitch date: 2025-01-02
KZR [bullish]
Kezar Life Sciences, Inc.
-5.03%
current return
Author Info
No bio for this author
Company Info
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
Market Cap
$45.1M
Pitch Price
$6.57
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.61
P/E
-0.64
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Kezar Life Sciences (KZR): High Cash, Low Valuation, Big Potential Upside
KZR: $49M mkt cap, $138M net cash, $16M/q burn. Portola AIH study data 1H25. Success = stock up. Failure = trade at 0.5x net cash. Activist owns 10%, bid $11/sh. Burn to decline. Nasdaq listing, NOLs. Event-driven biotech play with downside protection.
Read full article (1 min)